← Explorer/Network

Current Aspects of the Role of Autoantibodies Directed Against Appetite-Regulating Hormones and the Gut Microbiome in Eating Disorders

Kvido Smitka, Petra Procházková, Radka Roubalová +7 more2021Frontiers in EndocrinologyReview
10.3389/fendo.2021.613983PubMedFree full text
Endocrine (ADH/ACTH/MSH)GastrointestinalImmune/InnateNeurological

Abstract

The equilibrium and reciprocal actions among appetite-stimulating (orexigenic) and appetite-suppressing (anorexigenic) signals synthesized in the gut, brain, microbiome and adipose tissue (AT), seems to play a pivotal role in the regulation of food intake and feeding behavior, anxiety, and depression. A dysregulation of mechanisms controlling the energy balance may result in eating disorders such as anorexia nervosa (AN) and bulimia nervosa (BN). AN is a psychiatric disease defined by chronic self-induced extreme dietary restriction leading to an extremely low body weight and adiposity. BN is defined as out-of-control binge eating, which is compensated by self-induced vomiting, fasting, or excessive exercise. Certain gut microbiota-related compounds, like bacterial chaperone protein Escherichia coli caseinolytic protease B (ClpB) and food-derived antigens were recently described to trigger the production of autoantibodies cross-reacting with appetite-regulating hormones and neurotransmitters. Gut microbiome may be a potential manipulator for AT and energy homeostasis. Thus, the regulation of appetite, emotion, mood, and nutritional status is also under the control of neuroimmunoendocrine mechanisms by secretion of autoantibodies directed against neuropeptides, neuroactive metabolites, and peptides. In AN and BN, altered cholinergic, dopaminergic, adrenergic, and serotonergic relays may lead to abnormal AT, gut, and brain hormone secretion. The present review summarizes updated knowledge regarding the gut dysbiosis, gut-barrier permeability, short-chain fatty acids (SCFA), fecal microbial transplantation (FMT), blood-brain barrier permeability, and autoantibodies within the ghrelin and melanocortin systems in eating disorders. We expect that the new knowledge may be used for the development of a novel preventive and therapeutic approach for treatment of AN and BN.

Symptom Clusters

AnxietyDepression

Cited By (1)

  • The Microbiota–Gut–Brain Axis: Psychoneuroimmunological InsightsNutrients · 2023

Related Papers

  • The Role of Adipokines and Myokines in the Pathogenesis of Different Obesity Phenotypes—New PerspectivesAntioxidants · 2023 · 4 shared tags
  • Herbal Therapeutics for CIRS Biomarkers in Autism Spectrum Disorders: A Mechanistic and Molecular Approach for Neuroimmune Pathology in PediatricsMedical Research Archives · 2025 · 4 shared tags
  • Alterations in Gut Microbiota and Upregulations of VPAC2 and Intestinal Tight Junctions Correlate with Anti-Inflammatory Effects of Electroacupuncture in Colitis Mice with Sleep FragmentationBiology · 2022 · 4 shared tags
  • Role of short‐chain fatty acids in host physiologyAnimal Models and Experimental Medicine · 2024 · 4 shared tags
  • FOXO1 orchestrates the intestinal homeostasis via neuronal signaling in group 3 innate lymphoid cellsThe Journal of Experimental Medicine · 2023 · 4 shared tags
  • Gut Metabolites Acting on the Gut-Brain Axis: Regulating the Functional State of MicrogliaAging and Disease · 2023 ·
4 shared tags